Background: Carotenoids may reduce lung carcinogenesis because of their ant
ioxidant properties; however, few studies have examined the relation betwee
n intakes of individual carotenoids and lung cancer risk.
Objective: The aim of this study was to examine the relation between lung c
ancer risk and intakes of alpha-carotene, beta-carotene, lutein, lycopene,
and beta-cryptoxanthin in 2 large cohorts.
Design: During a 10-y follow-up period, 275 new cases of lung cancer were d
iagnosed in 46924 men; during a 12-y follow-up period. 519 new cases were d
iagnosed in 77283 women. Carotenoid intakes were derived from the reported
consumption of fruit and vegetables on food-frequency questionnaires admini
stered at baseline and during follow-up. The data were analyzed separately
for each cohort and the results were pooled to compute overall relative ris
ks (RRs).
Results: In the pooled analyses, alpha-carotene and lycopene intakes were s
ignificantly associated with a lower risk of lung cancer; the association w
ith beta-carotene. lutein, and beta-cryptoxanthin intakes were inverse but
not significant. Lung cancer risk was significantly lower in subjects who c
onsumed a diet high in a variety of carotenoids (RR: 0.68; 95% CI: 0.49, 0.
94 for highest compared with lowest total carotenoid score category). Inver
se associations were strongest after a 4-8-y lag between dietary assessment
and date of diagnosis. In subjects who never smoked, a 63% lower incidence
of lung cancer was observed for the top compared with the bottom quintile
of alpha-carotene intake (RR: 0.37. 95% CI: 0.18. 0.77).
Conclusion: Data from 2 cohort studies suggest that several carotenoids may
reduce the risk of lung cancer.